Cristallovar en es it fr

Cristallovar Brand names, Cristallovar Analogs

Cristallovar Brand Names Mixture

  • Cimicifuga Plex (Caulophyllum Thalictroides + Cimicifuga Racemosa + Copper + Cotton Plant + Estrone + Histamine Dihydrochloride + Hypothalamus + Magnesium Phosphate Dibasic + Pituitary Whole + Platinum + Sepia Officinalis L + Thyroid)
  • Holis 98 (Dioscorea Vilosa + Estrone + Salvia + Saw Palmetto)

Cristallovar Chemical_Formula

C18H22O2

Cristallovar RX_link

No information avaliable

Cristallovar fda sheet

Cristallovar msds (material safety sheet)

Cristallovar MSDS

Cristallovar Synthesis Reference

G. Anner, K. Miescher, and Helv. Chem. Acta. 31, 2173(1948)

Cristallovar Molecular Weight

270.366 g/mol

Cristallovar Melting Point

254.5-256 oC

Cristallovar H2O Solubility

3 g/100mL

Cristallovar State

Solid

Cristallovar LogP

4.067

Cristallovar Dosage Forms

Vaginal cream; Vaginal suppository; Patch; Skin gel; Tablet; IM injectable suspension

Cristallovar Indication

For management of Menopausal and postmenopausal disorders

Cristallovar Pharmacology

Estrone, a synthetically prepared or naturally occurring steroidal estrogen obtained from pregnant equine urine, is the primary circulating estrogen after menopause. Estrone is naturally derived from the peripheral conversion of androstenedione by an aromatase enzyme found in adipose tissues and is converted to estradiol in peripheral tissues. Estropipate is piperazine-stabilized estrone sulfate. Estrone, and estropipate are used to treat abnormalities related to gonadotropin hormone dysfunction, vasomotor symptoms, atrophic vaginitis, and vulvar atrophy associated with menopause, and for the prevention of osteoporosis due to estrogen deficiency.

Cristallovar Absorption

43%

Cristallovar side effects and Toxicity

Symptoms of overdose include nausea and vomiting. Withdrawal bleeding may occur in females.

Cristallovar Patient Information

Cristallovar Organisms Affected

Humans and other mammals